• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Events
  • Education
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Respiratory charities set to merge

13th December 2019 by PIP editor Leave a Comment

 

The final steps have been taken to enable the merger to go ahead, which the charities have said will ‘bring significant benefits for those with lung disease’.

 

Around 10,000 people in the UK are newly diagnosed with a lung disease each week, leading to more than 700,000 hospital admissions each year.

 

Asthma UK members voted in favour of the move at the beginning of the month, followed by British Lung Foundation trustees this week.

 

The new partnership will build on previous collaboration between the two organisations, including air quality campaigning and respiratory health research, and is expected to reduce running costs by as much as £2m.

 

Chief executive of the Asthma UK and British Lung Foundation Partnership Kay Boycott says the move creates an organisation fit for the future:

 

“This marks the start of a new era which promises to bring significant benefits to people affected by asthma and other lung diseases.

 

“Bringing together our joint vision and strategy will allow us to make even more impact, with more money to spend on ground-breaking research and support.

 

“Our new organisation will combine the energy and passion of the UK’s top respiratory health charities, creating a powerful voice for change.

 

“It is an absolute privilege to be the first chief executive of the new organisation leading the start-up of this innovative new venture.”

 

Leading experts in asthma and lung health are publicly supporting the merger – including the University of Aberdeen’s Professor of general practice, Sir Lewis Ritchie and the University of Edinburgh primary care research and development chair, Professor Aziz Sheikh – saying it will bring real benefits to patients now and in years to come.

 

The core charitable activities of both organisations – research programmes, campaigning, helplines, and websites –will continue and the British Lung Foundation and Asthma UK brands will still be used.

 

 

This story was supplied as part of our partnership with healthandcare.scot. 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Scotland excess deaths highest since 1940

Filed Under: News

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Resitters: The forgotten pre-registration pharmacist cohort

Pharmacies should be allowed to supply rapid antibody tests

Community pharmacists can identify high-risk asthmatic patients

Why is a decision on the pre-reg exam problem taking so long?

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.